Constructive Bio

Constructive Bio is a biotech company in Cambridge, United Kingdom, founded in 2021. It has raised $73.0M across 2 rounds, most recently a $58.0M Series A in September 2024.

Life, reimagined.

Headquarters
Cambridge
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$73.0M
Last Round
$58.0M Series ASep 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Constructive Bio is a Cambridge-based synthetic genomics company spun out from the laboratory of Prof. Jason Chin at the MRC Laboratory of Molecular Biology. The company uses the world's first fully synthetic recoded organism to produce therapeutics with chemistries that natural biology cannot access, combining de-novo genome synthesis with engineered translation. Its platform enables the incorporation of non-canonical amino acids into peptides and proteins at scale, unlocking new classes of enzymes, pharmaceuticals, and biomaterials. Constructive Bio's technology is built on peer-reviewed science published in Nature, Science, and Nature Chemistry.

Summary

It lists 11–50 employees. It has raised $73.0M in total across 2 rounds, most recently a $58.0M Series A round in Sep 2024. Investors include Ahren Innovation Capital, OMX Ventures and Paladin Capital Group.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ASep 2024
$58.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Constructive Bio on Indexed.vc
<a href="https://indexed.vc/companies/constructive-bio"><img src="https://indexed.vc/api/badge/company/constructive-bio" alt="Constructive Bio on Indexed.vc" width="260" height="76" /></a>